Report Detail

Pharma & Healthcare Global Oral Antidiabetic Drugs Market Professional Survey Report 2019

  • RnM3811881
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 101 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Oral Antidiabetic Drugs

      • 1.1 Definition of Oral Antidiabetic Drugs
      • 1.2 Oral Antidiabetic Drugs Segment by Type
        • 1.2.1 Global Oral Antidiabetic Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Sulfonylureas
        • 1.2.3 Meglitinides
        • 1.2.4 Alpha-glucosidase inhibitors
      • 1.3 Oral Antidiabetic Drugs Segment by Applications
        • 1.3.1 Global Oral Antidiabetic Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Oral Antidiabetic Drugs Overall Market
        • 1.4.1 Global Oral Antidiabetic Drugs Revenue (2014-2025)
        • 1.4.2 Global Oral Antidiabetic Drugs Production (2014-2025)
        • 1.4.3 North America Oral Antidiabetic Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Oral Antidiabetic Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Oral Antidiabetic Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Oral Antidiabetic Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Oral Antidiabetic Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Oral Antidiabetic Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs
      • 2.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
      • 2.4 Industry Chain Structure of Oral Antidiabetic Drugs

      3 Development and Manufacturing Plants Analysis of Oral Antidiabetic Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Oral Antidiabetic Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Oral Antidiabetic Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Oral Antidiabetic Drugs Production and Capacity Analysis
      • 4.2 Oral Antidiabetic Drugs Revenue Analysis
      • 4.3 Oral Antidiabetic Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Oral Antidiabetic Drugs Regional Market Analysis

      • 5.1 Oral Antidiabetic Drugs Production by Regions
        • 5.1.1 Global Oral Antidiabetic Drugs Production by Regions
        • 5.1.2 Global Oral Antidiabetic Drugs Revenue by Regions
      • 5.2 Oral Antidiabetic Drugs Consumption by Regions
      • 5.3 North America Oral Antidiabetic Drugs Market Analysis
        • 5.3.1 North America Oral Antidiabetic Drugs Production
        • 5.3.2 North America Oral Antidiabetic Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Oral Antidiabetic Drugs Import and Export
      • 5.4 Europe Oral Antidiabetic Drugs Market Analysis
        • 5.4.1 Europe Oral Antidiabetic Drugs Production
        • 5.4.2 Europe Oral Antidiabetic Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Oral Antidiabetic Drugs Import and Export
      • 5.5 China Oral Antidiabetic Drugs Market Analysis
        • 5.5.1 China Oral Antidiabetic Drugs Production
        • 5.5.2 China Oral Antidiabetic Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Oral Antidiabetic Drugs Import and Export
      • 5.6 Japan Oral Antidiabetic Drugs Market Analysis
        • 5.6.1 Japan Oral Antidiabetic Drugs Production
        • 5.6.2 Japan Oral Antidiabetic Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Oral Antidiabetic Drugs Import and Export
      • 5.7 Southeast Asia Oral Antidiabetic Drugs Market Analysis
        • 5.7.1 Southeast Asia Oral Antidiabetic Drugs Production
        • 5.7.2 Southeast Asia Oral Antidiabetic Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Oral Antidiabetic Drugs Import and Export
      • 5.8 India Oral Antidiabetic Drugs Market Analysis
        • 5.8.1 India Oral Antidiabetic Drugs Production
        • 5.8.2 India Oral Antidiabetic Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Oral Antidiabetic Drugs Import and Export

      6 Oral Antidiabetic Drugs Segment Market Analysis (by Type)

      • 6.1 Global Oral Antidiabetic Drugs Production by Type
      • 6.2 Global Oral Antidiabetic Drugs Revenue by Type
      • 6.3 Oral Antidiabetic Drugs Price by Type

      7 Oral Antidiabetic Drugs Segment Market Analysis (by Application)

      • 7.1 Global Oral Antidiabetic Drugs Consumption by Application
      • 7.2 Global Oral Antidiabetic Drugs Consumption Market Share by Application (2014-2019)

      8 Oral Antidiabetic Drugs Major Manufacturers Analysis

      • 8.1 Eli Lilly
        • 8.1.1 Eli Lilly Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.1.2 Eli Lilly Product Introduction, Application and Specification
        • 8.1.3 Eli Lilly Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Abbott
        • 8.2.1 Abbott Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.2.2 Abbott Product Introduction, Application and Specification
        • 8.2.3 Abbott Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biocon
        • 8.3.1 Biocon Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.3.2 Biocon Product Introduction, Application and Specification
        • 8.3.3 Biocon Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sanofi
        • 8.4.1 Sanofi Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.4.2 Sanofi Product Introduction, Application and Specification
        • 8.4.3 Sanofi Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Sunpharma
        • 8.5.1 Sunpharma Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.5.2 Sunpharma Product Introduction, Application and Specification
        • 8.5.3 Sunpharma Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novartis
        • 8.6.1 Novartis Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.6.2 Novartis Product Introduction, Application and Specification
        • 8.6.3 Novartis Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Novo Nordisk
        • 8.7.1 Novo Nordisk Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.7.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.7.3 Novo Nordisk Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Merck
        • 8.8.1 Merck Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.8.2 Merck Product Introduction, Application and Specification
        • 8.8.3 Merck Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Pfizer
        • 8.9.1 Pfizer Oral Antidiabetic Drugs Production Sites and Area Served
        • 8.9.2 Pfizer Product Introduction, Application and Specification
        • 8.9.3 Pfizer Oral Antidiabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Oral Antidiabetic Drugs Market

      • 9.1 Global Oral Antidiabetic Drugs Market Trend Analysis
        • 9.1.1 Global Oral Antidiabetic Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Oral Antidiabetic Drugs Regional Market Trend
        • 9.2.1 North America Oral Antidiabetic Drugs Forecast 2019-2025
        • 9.2.2 Europe Oral Antidiabetic Drugs Forecast 2019-2025
        • 9.2.3 China Oral Antidiabetic Drugs Forecast 2019-2025
        • 9.2.4 Japan Oral Antidiabetic Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Oral Antidiabetic Drugs Forecast 2019-2025
        • 9.2.6 India Oral Antidiabetic Drugs Forecast 2019-2025
      • 9.3 Oral Antidiabetic Drugs Market Trend (Product Type)
      • 9.4 Oral Antidiabetic Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Oral Antidiabetic Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.

        The global Oral Antidiabetic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Oral Antidiabetic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Antidiabetic Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Oral Antidiabetic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Oral Antidiabetic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Eli Lilly
        Abbott
        Biocon
        Sanofi
        Sunpharma
        Novartis
        Novo Nordisk
        Merck
        Pfizer

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Sulfonylureas
        Meglitinides
        Alpha-glucosidase inhibitors

        Segment by Application
        Hospitals
        Clinics
        Others


        Summary:
        Get latest Market Research Reports on Oral Antidiabetic Drugs. Industry analysis & Market Report on Oral Antidiabetic Drugs is a syndicated market report, published as Global Oral Antidiabetic Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Oral Antidiabetic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,713.45
        4,070.17
        5,426.90
        3,141.64
        4,712.45
        6,283.27
        379,907.50
        569,861.25
        759,815.00
        248,972.15
        373,458.23
        497,944.30
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report